Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
894 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05178693 | Lutathera and ASTX727 in Neuroendocrine Tumours(LANTana) | recruiting | Phase 1 | 27 | Imperial College LondonOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05768178 | DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.(DETERMINE) | recruiting | Phase 2 / Phase 3 | 30 | Cancer Research UKOTHER | 1 | Nov 24, 2025 |
| clinicaltrials |
| NCT05770037 | DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers(DETERMINE) | recruiting | Phase 2 / Phase 3 | 30 | Cancer Research UKOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05770102 | DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition(DETERMINE) | recruiting | Phase 2 / Phase 3 | 30 | Cancer Research UKOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT05770544 | DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.(DETERMINE) | recruiting | Phase 2 / Phase 3 | 30 | Cancer Research UKOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06126731 | Combination Study of Antibiotics With Enzalutamide (PROMIZE) | recruiting | Phase 1 / Phase 2 | 39 | Institute of Cancer Research, United KingdomOTHER | 2 | Nov 24, 2025 | clinicaltrials |
| NCT06988475 | DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations(DETERMINE) | recruiting | Phase 2 / Phase 3 | 30 | Cancer Research UKOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT04795882 | A New Study Evaluating the Activity of Modular CAR T for mYeloma(MCARTY) | recruiting | Phase 1 | 27 | University College, LondonOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT06063551 | Cryopreservation of Prepubertal Testicular Tissue for Preservation of Fertility in Young Boys With Cancer | recruiting | N/A | 100 | University of EdinburghOTHER | 1 | Nov 20, 2025 | clinicaltrials |
| NCT03572192 | Tissue Collection Framework To Improve Outcomes In Solid Tumours | recruiting | — | 3,000 | Queen Mary University of LondonOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT04624399 | Neoadjuvant Immune Checkpoint Inhibitor Treatment in Urothelial Cancer(ABACUS-2) | recruiting | Phase 2 | 58 | Queen Mary University of LondonOTHER | 1 | Nov 18, 2025 | clinicaltrials |
| NCT02848274 | ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome | recruiting | — | 2,000 | Stanford UniversityOTHER | 7 | Oct 22, 2025 | clinicaltrials |
| NCT06174987 | A Study to Provide Continued Access to and Assess Long-Term Safety of the Study Drug(s) | recruiting | Phase 3 | 50 | Daiichi SankyoINDUSTRY | 12 | Oct 15, 2025 | clinicaltrials |
| NCT07206394 | Feasibility Trial of ScarWork for Post-breast Surgery Pain Syndrome. | recruiting | N/A | 40 | University College London HospitalsOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT05331066 | Understanding immunE-related toXicities by multifACeT Profiling(EXACT) | recruiting | — | 200 | Royal Marsden NHS Foundation TrustOTHER | 1 | Oct 1, 2025 | clinicaltrials |
| NCT02705846 | Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations(GENPROS) | recruiting | — | 4,260 | Institute of Cancer Research, United KingdomOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT06320067 | A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer(STAMPEDE2) | recruiting | Phase 3 | 3,360 | University College, LondonOTHER | 1 | Sep 26, 2025 | clinicaltrials |
| NCT07144306 | AI-Driven Early Detection of Skin Cancer(Skin Cancer) | recruiting | — | 100 | Nuvana Healthcare LTDINDUSTRY | 1 | Sep 26, 2025 | clinicaltrials |
| NCT05971108 | Real-world Elecsys® GAAD Implementation and Validation to Improve Surveillance and Early Detection of HCC(REVISE-HCC) | recruiting | N/A | 600 | Manchester University NHS Foundation TrustOTHER_GOV | 1 | Sep 24, 2025 | clinicaltrials |
| NCT07189806 | Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma(MAPLE-UK) | recruiting | — | 250 | HvivoINDUSTRY | 1 | Sep 24, 2025 | clinicaltrials |
| NCT05184582 | Physical Exercise During Preoperative Chemotherapy for Breast Cancer(Neo-ACT) | recruiting | N/A | 712 | Karolinska InstitutetOTHER | 4 | Sep 22, 2025 | clinicaltrials |
| NCT06658782 | Abbreviated Magnetic Resonance Imaging vs Ultrasound Surveillance for Liver Cancer dETection in People at High Risk of Developing Liver Cancer(AMULET) | recruiting | — | 300 | University of OxfordOTHER | 1 | Sep 22, 2025 | clinicaltrials |
| NCT05329532 | Modi-1 Moditope in Breast, Head and Neck, Ovarian, or Renal Cancer(ModiFY) | recruiting | Phase 1 / Phase 2 | 168 | Scancell LtdINDUSTRY | 1 | Sep 17, 2025 | clinicaltrials |
| NCT05658640 | HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies(HEM-iSMART D) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 15 | Sep 16, 2025 | clinicaltrials |
| NCT05745714 | HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies(HEM-iSMART C) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 14 | Sep 16, 2025 | clinicaltrials |
| NCT05751044 | HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies(HEM-iSMART B) | recruiting | Phase 1 / Phase 2 | 26 | Princess Maxima Center for Pediatric OncologyOTHER | 14 | Sep 16, 2025 | clinicaltrials |
| NCT07167251 | Management of Immune Checkpoint Inhibition-related Hepatitis Using Low-dose Corticosteroids(MIRA-HEP) | recruiting | — | 63 | University Hospital, Basel, SwitzerlandOTHER | 2 | Sep 11, 2025 | clinicaltrials |
| NCT05449691 | Biological Matrices Versus Synthetic Meshes(BIOSYM) | recruiting | N/A | 60 | University Hospitals of Derby and Burton NHS Foundation TrustOTHER | 1 | Sep 10, 2025 | clinicaltrials |
| NCT05107674 | A Study of NX-1607 in Adults With Advanced Malignancies | recruiting | Phase 1 | 345 | Nurix Therapeutics, Inc.INDUSTRY | 2 | Sep 9, 2025 | clinicaltrials |
| NCT05372354 | A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma | recruiting | Phase 1 / Phase 2 | 260 | Bristol-Myers SquibbINDUSTRY | 5 | Sep 5, 2025 | clinicaltrials |
| NCT05903430 | A Feasibility Study of MRI Guided Stereotactic Ablative Radiotherapy (MIDSECTION)(MIDSECTION) | recruiting | — | 60 | The Christie NHS Foundation TrustOTHER | 1 | Sep 5, 2025 | clinicaltrials |
| NCT05180864 | Omentum Preservation Versus Complete Omentectomy in Gastrectomy for Gastric Cancer(OMEGA-2) | recruiting | N/A | 654 | Amsterdam UMCOTHER | 4 | Sep 4, 2025 | clinicaltrials |
| NCT07136753 | MIBREAST Making in Immediate Breast REconstruction And the Measurement of the EffectS of RadioTherapy(MIBREAST) | recruiting | — | 300 | Royal Marsden NHS Foundation TrustOTHER | 1 | Aug 22, 2025 | clinicaltrials |
| NCT07075016 | Ivosidenib and Azacitidine With or Without Venetoclax in Adult Patients With Newly Diagnosed IDH1-Mutated AML or MDS/AML Considered Ineligible for Intensive Chemotherapy(EVOLVE 1) | recruiting | Phase 3 | 227 | Stichting Hemato-Oncologie voor Volwassenen NederlandOTHER | 16 | Aug 19, 2025 | clinicaltrials |
| NCT06645236 | DHF-20-1839-2: Clinical Performance Study Protocol for Therascreen® KRAS RGQ PCR Kit | recruiting | N/A | 600 | QIAGEN Gaithersburg, IncINDUSTRY | 1 | Aug 15, 2025 | clinicaltrials |
| NCT06868355 | APACE - Feasibility of Using Accelerometers to Measure Physical Activity in Cancer Patients on Early Phase Clinical Trials(APACE) | recruiting | — | 40 | University of ManchesterOTHER | 3 | Aug 14, 2025 | clinicaltrials |
| NCT06976892 | Investigating Idetrexed and Olaparib in Patients With Ovarian Cancer(IDOL) | recruiting | Phase 1 | 33 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 13, 2025 | clinicaltrials |
| NCT03740893 | PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast Cancer(PHOENIX) | recruiting | Phase 2 | 119 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT07116642 | Comparing Patient Reported Outcomes and Clinical Outcomes Based on Different Scar Placement in Patients Undergoing Standard Breast Conserving Surgery for Breast Cancer: The PROM-S Study.(PROM-S) | recruiting | — | 100 | The Leeds Teaching Hospitals NHS TrustOTHER | 1 | Aug 11, 2025 | clinicaltrials |
| NCT07104955 | Salutare One Referral Software Impact on Multi-Disciplinary Team (MDT) Meetings Effectiveness and Safety | recruiting | N/A | 40 | Salutare Group Ltd.INDUSTRY | 1 | Aug 5, 2025 | clinicaltrials |
| NCT05650125 | A Platform Study for solId orgaN CancERs(PINCER) | recruiting | — | 2,000 | University of LiverpoolOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT06154785 | Low Stable Pressure Pneumoperitoneum in Colorectal Surgery (CROSS STUDY)(CROSS) | recruiting | — | 300 | Bordeaux Colorectal Institute AcademyOTHER | 8 | Aug 1, 2025 | clinicaltrials |
| NCT06762769 | Isatuximab and Iberdomide as Immunotherapy for High Risk in Smouldering Myeloma(MODIFY) | recruiting | Phase 2 | 63 | University College, LondonOTHER | 1 | Aug 1, 2025 | clinicaltrials |
| NCT06064461 | Vitaccess Real MG Registry(VRMG) | recruiting | — | 600 | Vitaccess LtdINDUSTRY | 2 | Jul 29, 2025 | clinicaltrials |
| NCT06045910 | A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies | recruiting | Phase 1 / Phase 2 | 84 | Cancer Research UKOTHER | 1 | Jul 28, 2025 | clinicaltrials |
| NCT02543905 | The PROFILE Study: Germline Genetic Profiling: Correlation With Targeted Prostate Cancer Screening and Treatment(PROFILE) | recruiting | — | 1,600 | Institute of Cancer Research, United KingdomOTHER | 1 | Jul 25, 2025 | clinicaltrials |
| NCT05574647 | Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer(IP7-PACIFIC) | recruiting | N/A | 3,600 | Imperial College LondonOTHER | 1 | Jul 24, 2025 | clinicaltrials |
| NCT07051044 | Rapid Absorbance-based Detection of Inner Cheek Cell Abnormalities Using Light Spectroscopy for Risk Evaluation of Lung Cancer to Enable Critical Decision Support in Targeted Patient Populations(RADICAL-REACT) | recruiting | — | 450 | Sierra Medical Ltd.INDUSTRY | 1 | Jul 3, 2025 | clinicaltrials |
| NCT06560905 | Preoperative Planning With PSMA-PET in Melanoma Surgery Trial(PPPIMS) | recruiting | Phase 2 | 16 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jul 1, 2025 | clinicaltrials |
| NCT05549102 | CBT and the Neural Circuits of Anxiety | recruiting | — | 174 | UCLH/UCL Joint Research OfficeOTHER | 1 | Jun 29, 2025 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials